Skip to content

Telix Pharmaceuticals

US · TLX #2345 by market cap Listed 2024
8.37 -0.34 -3.90%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
C-
Momentum strategy signal
Sell
Analyst consensus
Buy

Signals diverge - worth digging into why.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 2 analysts

Buy
Avg price target 20.00 +138.9%
Price target rangecurrent 8.37
Low20.00
Avg20.00
High20.00
Buy 100% Hold 0% Sell 0%
Recent ratings (3)
DateFirmAnalystRatingTarget
2026-09-30 H.C. Wainwright -- Buy 20.00
2026-09-25 H.C. Wainwright -- Buy 20.00
2026-09-22 William Blair -- Buy --

Earnings history price reaction on the day

PeriodReport dateSessionActual move
2026/Q2 2026-08-19 After close +2.48%
2025/Q4 2026-02-19 After close +14.61%
2025/Q2 2025-08-20 After close +10.21%
2024/Q4 2025-02-19 After close +1.28%

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Telix Pharmaceuticals discussion 0 comments

Add a comment